DelveInsight’s “Patient Monitoring Devices – Market Insight, Competitive Landscape, and Market Forecast, 2030” report provides in-depth analysis of patient monitoring devices market dynamics, epidemiology trends, and emerging technologies that will shape the future of patient monitoring. The global patient monitoring devices market, valued at approximately USD 35 billion in 2023, is projected to grow at a CAGR of 8.20% during the forecast period from 2024 to 2030, reaching ~USD 56 billion by 2030. This growth trajectory reflects the escalating demand for technologies that enable continuous assessment of vital parameters across diverse healthcare environments.
North America currently dominates the patient monitoring devices market, driven by high chronic disease prevalence, advanced healthcare infrastructure, and favorable reimbursement policies. The region’s leadership is further strengthened by government initiatives supporting remote patient monitoring programs and telemedicine services, which were particularly accelerated by healthcare adaptations during the COVID-19 pandemic. Meanwhile, the Asia Pacific region is anticipated to experience the fastest growth during the forecast period, propelled by increasing healthcare expenditure and rising disease burden.
Download the Patient Monitoring Devices Market Forecast Report to understand which factors are driving the Patient Monitoring Devices market @ Patient Monitoring Devices Market Trends.
The epidemiological landscape underscores the urgent need for advanced monitoring solutions. Currently, nearly 600 million adults worldwide are living with diabetes – approximately one in nine individuals – with projections indicating this number will surge to over 850 million by 2050. Similarly, cardiovascular diseases remain the leading global cause of mortality, affecting more than 620 million people and causing approximately 21 million deaths annually. These statistics highlight the critical role of continuous monitoring in disease management and early intervention strategies.
Within the market segments, cardiac monitoring devices hold a significant share, primarily due to the high global burden of cardiovascular disorders. Blood glucose monitoring systems are also witnessing substantial growth, currently representing approximately 24% of the market share, as diabetes management increasingly relies on real-time data to optimize treatment outcomes.
Download the Patient Monitoring Devices Competitive Landscape Report for in-depth Patient Monitoring Devices competitive insights.
Recent developments in the market showcase the industry’s innovation trajectory. In November 2024, BioIntelliSense received FDA approval for its BioButton Multi-Patient wearable and BioDashboard system, designed to enhance hospital-based virtual care programs and extend patient monitoring capabilities into home environments. Earlier in October 2024, the company also secured FDA clearance for its rechargeable BioButton Multi-Patient wearable, expanding its continuous patient monitoring portfolio with reusable solutions for automating vital sign collection across various healthcare settings. Additionally, Sibel Health announced in March 2025 the closing of $30 million in new equity funding to advance its remote monitoring technologies.
The integration of artificial intelligence, Internet of Medical Things (IoMT), and advanced biosensors is rapidly transforming patient monitoring capabilities. Smart monitoring devices with wireless connectivity enable seamless data transmission and analysis, which facilitates early detection of deterioration conditions and supports timely intervention. The shift toward value-based healthcare models is further accelerating the adoption of remote patient monitoring technologies that reduce hospital readmissions and improve patient outcomes while decreasing overall healthcare costs.
Discover evolving trends in the Patient Monitoring Devices landscape @ Patient Monitoring Devices Recent Developments.
Looking ahead, the patient monitoring devices market faces both opportunities and challenges. While technological advancements continue to enhance monitoring capabilities, issues related to data security, interoperability, and the high cost of premium devices remain significant barriers to universal adoption. Nevertheless, the market’s trajectory signals a transformative period in healthcare delivery, wherein continuous monitoring becomes increasingly integral to chronic disease management, preventive care, and personalized medicine approaches.
Table of Contents
1. Patient Monitoring Devices Market Report Introduction
2. Patient Monitoring Devices Market Executive Summary
3. Regulatory Analysis
4. Patient Monitoring Devices Market Key Factors Analysis
5. Patient Monitoring Devices Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Patient Monitoring Devices Market
7. Patient Monitoring Devices Market Layout
8. Patient Monitoring Devices Global Company Share Analysis – Key 3-5 Companies
9. Patient Monitoring Devices Company and Product Profiles
10. KOL Views
11. Project Approach
12. About DelveInsight
13. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Arpit AnandEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services
